Nanomedicine Therapeutics
4 days Time toFirst Decision
40 days Submission toAcceptance
5 days Acceptance toPublication
About the journal
Nanomedicine Therapeutics (NMT) is an international, peer-reviewed, open-access journal dedicated to advancing therapeutic nanomedicine. The journal focuses on innovative nanoscale systems that connect nanomaterial design with clinical applications, accelerating the translation of nanomedical discoveries into healthcare. Covering drug delivery, targeted therapy, theranostics, immunotherapy, regenerative medicine, and biomaterials, it provides a multidisciplinary platform for developing intelligent and precision nanotherapeutics.
1 / 6
26
Authors
74
Reviewers
2026
Published Since
Nanomedicine Therapeutics
Editor-in-Chief: Prof. Xiangyang Shi
Median time to first editorial decision: 4 days
4 days Time to First Decision
40 days Submission to Acceptance
Dendrimer-based hydrogels for biomedical applications
Prebiotic-integrated nanoplatforms for inflammatory bowel disease: from construction strategies to multimodal combination therapy
Stomatocytes as multifunctional therapeutic vehicles: opportunities and challenges for next generation nanomedicine
Bispecific gold nanoparticles enhance therapeutic efficacy in HER2-positive breast cancer
Topic: Engineering nanobiomaterials for therapeutic applications in brain diseases, inflammation, and tumors
Submission Deadline: 20 May 2027 Published articles: 0
Topic: From Dendrimers to Nanomedicine: Celebrating the 85th Birthday of Prof. Jean-Pierre Majoral
Submission Deadline: 15 Jan 2027 Published articles: 1
26
Authors
74
Reviewers
2026
Published Since














(1).jpg)























